<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02716454</url>
  </required_header>
  <id_info>
    <org_study_id>IBDchirCZ-01</org_study_id>
    <nct_id>NCT02716454</nct_id>
  </id_info>
  <brief_title>Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease</brief_title>
  <acronym>ESPRIT</acronym>
  <official_title>Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease - Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ondrej Ryska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Czech Surgical Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the efficacy of early surgical with medical treatment in patients with
      ileocaecal uncomplicated Crohn's disease. The patients with affected short part of terminal
      ileum will be randomized either for laparoscopic ileocaecal resection or standard step-up
      pharmacological therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical therapy is currently indicated for Crohn's disease (CD) patients after conservative
      treatment becomes ineffective. The principles of so-called step-up therapy (STUP) where
      surgery represents the last therapeutical option are still followed.

      Early surgical intervention (Early Surgery - ES) can be an alternative even in patients with
      uncomplicated type of CD before all medical therapy is used (Top-down approach). Limited
      resection under these conditions will lead to immediate remission. Moreover, laparoscopic
      ileocaecal resection is safe with low morbidity and regarding potential complications of
      step-up treatment might be beneficial for the patient.

      Before wide introduction of ES approach into clinical practice, it is necessary to perform a
      randomized trial comparing early resection with the standard step-up medical therapy.

      The potential effect of early, intensive therapy (ileocaecal resection) on biological
      behavior of the disease has not been studied that is why patients with uncomplicated
      ileocaecal form are the most suitable for such a trial. Significant number of these patients
      will indeed progress into more unfavorable course of the disease (relapse, complicated form,
      early recurrence).

      Other potential benefit of early resection is the extended period without necessary
      medication. Even pharmacological recurrence prevention is not needed after surgery in
      uncomplicated CD patient if other risk factors are excluded. Rapid remission induced by
      surgery can lead to faster improvement of quality of life than long-term medication.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endoscopic remission</measure>
    <time_frame>24 months</time_frame>
    <description>The rate of endoscopic remission defined as Rutgeerts score ≤ 1 and SES-CD = 0 in early surgery and standard step-up therapy group respectively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QoL</measure>
    <time_frame>24 months</time_frame>
    <description>Quality of life measured by IBDQ, IBD Disability index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical remission</measure>
    <time_frame>24 months</time_frame>
    <description>Clinical remission defined by Crohn's disease activity index &lt; 150</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug consumption</measure>
    <time_frame>24 months</time_frame>
    <description>Overall drug consumption (corticosteroids, antibiotics, immunomodulators, biologic therapy)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Early Surgery - ES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early laparoscopic ileocaecal resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Step-up therapy - STUP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Treatment with step-up conservative approach according to good clinical practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ileocaecal resection</intervention_name>
    <description>laparoscopic ileocaecal resection with primary anastomosis</description>
    <arm_group_label>Early Surgery - ES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  All patients aged 18-65 years with a uncomplicated ileocaecal form of Crohn's disease
             (affected &lt; 20 cm of terminal ileum) (type: L1B1) diagnosed within last 12 months

          -  Diagnose confirmed by endoscopy including appropriate extent of disease and presence
             of ulcers in terminal ileum

          -  Patient is able to understand the study and sign an informed consent

        Exclusion Criteria:

          -  Pregnant or breastfeeding women

          -  Previous bowel resection or other extensive abdominal surgery, which primarily
             excludes laparoscopic approach

          -  Affected other parts of the digestive tract or symptomatic stenosis or stenosis
             impassable for the endoscope or presence of prestenotic dilatation in terminal ileum
             confirmed by enterography

          -  Any extraluminal complications of Crohn's disease (fistula, abscess)

          -  Affected part of terminal ileum longer than 20 cm

          -  Severe comorbidities (heart failure, renal failure, liver failure, severe disorders of
             the central and peripheral nervous system, serious infectious disease) or patient with
             ASA (American Society of Anesthesiologists) III and more

          -  Malnutrition or presence of another serious risk factor, which contradicts
             construction of primary anastomosis

          -  Current use of immunosuppressive or biologic therapy

        Other exclusion criteria:

          -  Different intraoperative finding

          -  Protocol violation

          -  Subject refuses further participation in the study

          -  Termination of the trial by responsible authority
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ondrej Ryska, Dr, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section of IBD surgery - Czech Surgical Society</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ondrej Ryska, Dr, PhD</last_name>
    <phone>606254686</phone>
    <phone_ext>00420</phone_ext>
    <email>ondrejryska@centrum.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University Hospital Brno</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lenka Prokopova, Dr.</last_name>
      <email>lprokopova@fnbrno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Filip Marek, Dr.</last_name>
      <email>fmarek@fnbrno.cz</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Ceske Budejovice</name>
      <address>
        <city>Ceske Budejovice</city>
        <zip>370 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Shonova, Dr.</last_name>
      <email>shonova@nemcb.cz</email>
    </contact>
    <contact_backup>
      <last_name>M Kobza, Dr.</last_name>
      <email>mkobza@seznam.cz</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Horovice Hospital</name>
      <address>
        <city>Horovice</city>
        <zip>26831</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zuzana Serclova, Dr</last_name>
      <email>sercl@seznam.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitiy Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julius Orhalmi, Dr.</last_name>
      <email>orhalmi@volny.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Jihlava</name>
      <address>
        <city>Jihlava</city>
        <zip>586 33</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie Tomanova, Dr.</last_name>
      <email>tomanovam@nemji.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Liberec</name>
      <address>
        <city>Liberec</city>
        <zip>460 63</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lenka Nedbalova, Dr.</last_name>
      <email>lenka.nedbalova@nemlib.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vitkovice Hospital</name>
      <address>
        <city>Ostrava - Vitkovice</city>
        <zip>703 84</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital in Pilsen</name>
      <address>
        <city>Pilsen</city>
        <zip>323 18</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jana Kozeluhova, Dr.</last_name>
      <email>kozeluhova@fnplzen.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Vinohrady University Hospital</name>
      <address>
        <city>Prague</city>
        <zip>100 34</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pavel Lisý, Dr.</last_name>
      <email>lisy@fnkv.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>140 21</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pavel Drastich, Dr.</last_name>
      <email>drastich@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <zip>150 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karel Mareš, Dr</last_name>
      <email>karel.mares@homolka.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ISCARE</name>
      <address>
        <city>Prague</city>
        <zip>170 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dana Duricova, Dr</last_name>
      <email>dana.duricova@seznam.cz</email>
    </contact>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <reference>
    <citation>Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OØ, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007 Apr;13(4):481-9.</citation>
    <PMID>17206705</PMID>
  </reference>
  <reference>
    <citation>Domènech E, Zabana Y, Garcia-Planella E, López San Román A, Nos P, Ginard D, Gordillo J, Martínez-Silva F, Beltrán B, Mañosa M, Cabré E, Gassull MA. Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability. Aliment Pharmacol Ther. 2010 Jan 15;31(2):233-9. doi: 10.1111/j.1365-2036.2009.04170.x. Epub 2009 Oct 13.</citation>
    <PMID>19832727</PMID>
  </reference>
  <reference>
    <citation>Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut. 2005 Feb;54(2):237-41. Erratum in: Gut. 2005 May;54(5):734.</citation>
    <PMID>15647188</PMID>
  </reference>
  <reference>
    <citation>Golovics PA, Lakatos L, Nagy A, Pandur T, Szita I, Balogh M, Molnar C, Komaromi E, Lovasz BD, Mandel M, Veres G, Kiss LS, Vegh Z, Lakatos PL. Is early limited surgery associated with a more benign disease course in Crohn's disease? World J Gastroenterol. 2013 Nov 21;19(43):7701-10. doi: 10.3748/wjg.v19.i43.7701.</citation>
    <PMID>24282358</PMID>
  </reference>
  <reference>
    <citation>Eshuis EJ, Bemelman WA, van Bodegraven AA, Sprangers MA, Bossuyt PM, van Milligen de Wit AW, Crolla RM, Cahen DL, Oostenbrug LE, Sosef MN, Voorburg AM, Davids PH, van der Woude CJ, Lange J, Mallant RC, Boom MJ, Lieverse RJ, van der Zaag ES, Houben MH, Vecht J, Pierik RE, van Ditzhuijsen TJ, Prins HA, Marsman WA, Stockmann HB, Brink MA, Consten EC, van der Werf SD, Marinelli AW, Jansen JM, Gerhards MF, Bolwerk CJ, Stassen LP, Spanier BW, Bilgen EJ, van Berkel AM, Cense HA, van Heukelem HA, van de Laar A, Slot WB, Eijsbouts QA, van Ooteghem NA, van Wagensveld B, van den Brande JM, van Geloven AA, Bruin KF, Maring JK, Oldenburg B, van Hillegersberg R, de Jong DJ, Bleichrodt R, van der Peet DL, Dekkers PE, Goei TH, Stokkers PC. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial). BMC Surg. 2008 Aug 22;8:15. doi: 10.1186/1471-2482-8-15.</citation>
    <PMID>18721465</PMID>
  </reference>
  <reference>
    <citation>Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990 Oct;99(4):956-63.</citation>
    <PMID>2394349</PMID>
  </reference>
  <reference>
    <citation>Peyrin-Biroulet L, Cieza A, Sandborn WJ, Coenen M, Chowers Y, Hibi T, Kostanjsek N, Stucki G, Colombel JF; International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012 Feb;61(2):241-7. doi: 10.1136/gutjnl-2011-300049. Epub 2011 Jun 5.</citation>
    <PMID>21646246</PMID>
  </reference>
  <reference>
    <citation>Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP; European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis. 2010 Feb;4(1):28-62. doi: 10.1016/j.crohns.2009.12.002. Epub 2010 Jan 15. Erratum in: J Crohns Colitis. 2010 Sep;4(3):353. Dosage error in article text.</citation>
    <PMID>21122489</PMID>
  </reference>
  <reference>
    <citation>Maartense S, Dunker MS, Slors JF, Cuesta MA, Pierik EG, Gouma DJ, Hommes DW, Sprangers MA, Bemelman WA. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. Ann Surg. 2006 Feb;243(2):143-9; discussion 150-3.</citation>
    <PMID>16432345</PMID>
  </reference>
  <results_reference>
    <citation>Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R. Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther. 2007 Nov 15;26(10):1303-12. Epub 2007 Sep 10.</citation>
    <PMID>17848181</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2016</study_first_submitted>
  <study_first_submitted_qc>March 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Czech Surgical Society</investigator_affiliation>
    <investigator_full_name>Ondrej Ryska</investigator_full_name>
    <investigator_title>investigator secretary in section of IBD surgery Czech Surgical Society</investigator_title>
  </responsible_party>
  <keyword>Early surgery</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>Step-up therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

